Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. - Wikidata - awgldk - TriplyDB

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

http://www.wikidata.org/entity/Q35536357

about

Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosis Microbiology of airway disease in a cohort of patients with cystic fibrosis.Antibiotic treatment forStenotrophomonas maltophiliain people with cystic fibrosis Stenotrophomonas maltophilia: an emerging global opportunistic pathogen Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients Clinical significance of microbial infection and adaptation in cystic fibrosis.The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants.Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease.Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies Pseudomonas aeruginosa: the potential to immunise against infection.Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Exacerbations in cystic fibrosis. 1: Epidemiology and pathogenesis.Children and young adults with CF in the USA have better lung function compared with the UK.Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers.Intensive care management of the patient with cystic fibrosis.Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.Recurrent hemoptysis with Penicillium marneffei and Stenotrophomonas maltophilia in Job's syndrome.Update on antibiotics for infection control in cystic fibrosis.Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment.Current dilemmas in antimicrobial therapy in cystic fibrosis.The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement.Identification of new bacterial and fungal pathogens on surveillance bronchoscopy prior to sinus surgery in patients with cystic fibrosis.Evolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.Update on host-pathogen interactions in cystic fibrosis lung disease.Infection in cystic fibrosis: impact of the environment and climate.Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome.Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients.

P2860

Q24197517-BB9C7750-CEA5-43B2-BD1A-7B1C204F5396 Q24197766-CCAB1911-540C-4171-8F88-C86C4977FC11 Q25256069-F037B8F1-16C9-4BFD-857D-14BF456A881F Q26471114-0DCD84FE-E2BC-4C76-8471-A45E15D24843 Q26995336-7942F75D-13CB-4240-84F8-4D0E47288467 Q30413773-21B76AD3-364D-4056-B908-391E55191562 Q33310144-4D838AA2-C15E-42A9-A47F-DCB32B01768D Q33550582-DA883BF5-20BA-4321-A68B-DD32B83C2782 Q33688123-253E04FD-E10B-4C81-B387-48944530710D Q33697276-77AF790D-768D-4062-8F05-0DB2D5C2412E Q33874056-DA303AE0-7F5A-478D-8538-7D6B5AA16F9A Q34229243-2A6E3D73-5A7D-4565-9D07-7B8BE53E6F08 Q34491552-105D64F9-992A-4A0B-B3E8-5463FB75BD81 Q34770892-7703D4B4-D2BA-41BB-9B4E-B5D37AD399A4 Q35690337-C8D28E09-9BAB-415B-918D-4815E7391BE8 Q35827843-BB3EB910-1A40-456C-93F0-9862FD8D4B5C Q36194089-D8E2ADE8-6A07-4FCF-930B-0048F2E2BC0C Q36197194-418F5E52-8338-4AA0-A2B0-EFBF6BD01A0E Q36304192-A3769E71-D156-4C4C-AF68-51A1C7929F5A Q36670892-4C11DAE1-923D-40B7-BFA1-49DE0BB53C17 Q36771148-4F765EEA-5B36-4A29-A42F-ECD27A303C5B Q36818364-9D6AFAC0-A31D-466A-9BCA-B4F4BE15B554 Q36968540-6BCA66B1-5C9B-4899-9C2E-25815247FC86 Q36980425-38F696E6-AEF3-4C7B-A2CE-2E3D8DFB937E Q37149666-77514CF6-33A9-420C-9952-4FAD888C05E0 Q37265316-9E9FE545-A45F-455F-9B06-3745599DB14D Q37586980-0D116051-D650-427F-9764-AE0072D45BA4 Q37608274-DB2952EF-AED2-436C-8341-B28C257D56FC Q37866819-779A65FC-D0F3-4B21-A3D6-CE1916059834 Q38042719-ADD29FEE-5DC4-4BFE-81A7-0922C75DA28D Q38180124-702B7D81-C4F1-43E5-964F-8461CB3E1EB6 Q38204951-426FBFA6-C0A9-4AFB-A951-E98CD3F58829 Q38211644-871C1A03-7E72-40F8-B3A7-8D094BC69B62 Q38453923-42AFE2BB-055F-4986-8FD7-6CF41BFAB84E Q38605085-00E52C03-348B-4141-A6F7-975AF6963923 Q38763542-A391A265-312D-40E2-AC3D-8C03BFCFF1C4 Q39740434-FA435EC2-182D-426C-97C4-C77A63AD6C77 Q40090307-2B225F7D-6C7D-4B1F-AD64-CC961BD7C694 Q40252432-BF246062-5AFA-4CF6-AD85-DE6A686A47C5 Q40507596-50A49368-8A7F-4D64-B406-ECB478CB6BAA

P2860

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

http://www.wikidata.org/entity/Q35536357

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@ast

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@en

type

label

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@ast

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@en

prefLabel

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@ast

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.

@en

P1433

Q35536357-77DCF865-0D02-49A4-8387-CDC7157C0E94

P1476

Q35536357-062E2A7F-90E8-4D7C-BDBA-C299640D48CA

P2093

Q35536357-27EC5233-FF87-4320-A068-E864CFE1E18F

Q35536357-4D415C79-6217-4B32-9494-5CF2B3853279

Q35536357-500B6CFE-EC2D-43D6-A5C4-74DFEE732558

Q35536357-9DDF4F02-AF92-4C09-B2FD-66C50B21E6A9

P2860

Q35536357-1C33FE00-3127-45FE-91BB-42C096E6080D

Q35536357-1FF81C24-7CD1-4089-A14D-EFF41885C54D

Q35536357-38C5A372-FA2C-479A-83AB-0D9A6659BE7A

Q35536357-3FBCE0E6-A391-4E5A-A6B7-C8CBB35F0480

Q35536357-89DB0DCC-A033-4779-AE37-2368A4A2D90D

Q35536357-95DF1F2A-E97F-4DD6-A310-C9FE344EF5D7

Q35536357-9AE13E6F-C446-4DB6-905C-A6EEDD6941EF

Q35536357-B76857C9-D700-44BB-BEC7-BDCDE5092A96

Q35536357-C9F19E8A-DCC9-4711-999D-7B19215EAF24

Q35536357-CAC1088A-AE89-46D5-BE9B-124878633BFB

P304

Q35536357-1E6C35A1-5319-4072-82A4-CFC28F659144

P31

Q35536357-0A974C70-4DCE-491F-AC88-7859B9128631

P356

Q35536357-8770A411-9AE2-4E4F-BAE5-080E3226A7BC

P407

Q35536357-A6BE2248-2C80-443E-B406-DC7051381C6E

P433

Q35536357-B6B2CA0A-9D0C-400E-97EE-6FD6CA00009A

P478

Q35536357-9B4625F5-6FAD-4BA6-8D2B-2D661238E6CA

P50

Q35536357-91001D90-C924-4D77-85CA-B7A0CA3D9BDD

P577

Q35536357-95745CD9-DF7B-4E02-98D4-C8355F2F044F

P5875

Q35536357-8377DE2C-9C47-4C98-A395-866FBCFE01E8

P698

Q35536357-7E52B5F0-12F5-48B6-9910-61A4A2CF4C6E

P921

Q35536357-D9D1D583-63FC-4668-B5DC-F5AB550570A6

P932

Q35536357-1FAB5475-161F-4931-8700-B501EDCC4DAC

P356

THX.2003.017707

P1433

P1476

Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis

@en

P2093

Aitken ML

http://www.w3.org/2001/XMLSchema#string

Mayer-Hamblett N

http://www.w3.org/2001/XMLSchema#string

Ramsey BW

http://www.w3.org/2001/XMLSchema#string

Rubenfeld GD

http://www.w3.org/2001/XMLSchema#string

P2860

Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

Pulmonary infections in patients with cystic fibrosis.

Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis.

Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis

Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis

Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients.

Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Microbiology of sputum from patients at cystic fibrosis centers in the United States.

P304

955-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2003.017707

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

Christopher H Goss

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8204835

http://www.w3.org/2001/XMLSchema#string

P698

15516471

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

1746887

http://www.w3.org/2001/XMLSchema#string